A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions.

Authors :: Cortellini, A.
Barrichello, A.P.C.
Alessi, J.V.
Ricciuti, B.
Vaz, V.R.
Newsom-Davis, T.
Evans, J.S.
Lamberti, G.
Pecci, F.
Viola, P.
D'Alessio, A.
Fulgenzi, C.A.M.
Awad, M.M.
Pinato, D.J.
Source :: Annals of Oncology. Nov2022, Vol. 33 Issue 11, p1202-1204. 3p.
Publication Year :: 2022

Subjects :: *NON-small-cell lung carcinoma
*TREATMENT effectiveness
*PEMBROLIZUMAB
*MORNING

Full Text Access

Tools